The Duluth Stock Exchange has taken a new look at the market, reporting on a new trade.
The trading post on Wednesday reported that the Duluth Women’s Stock Exchange (DWSAX) is buying $6 million worth of shares of StemHealth in the latest round of financing.
The deal was announced in October by Dr. Karen Schoenebeck, CEO of St. Jude Children’s Research Hospital, and her husband, Michael Schoenesb.
The company has already announced a $100 million round of funding to help it meet its goal of generating $300 million by 2020.
St. Joseph Medical has a long history of investments in healthcare, including the $3.4 billion purchase of HorizonCare in 2009.
Schoenerb’s company has a portfolio of medical products, including vaccines, medications, biologics, and blood products.
The purchase of Stereobox shares in September was a $1.3 million deal.
The St. Louis Post Dispatch reported on the St. Peters Healthcare fund, which is in the process of raising a $25 million round, in December.
Shares of Stemeda Pharmaceuticals are up more than 15% in 2017.
The firm is also building a $250 million clinical development center in Duluth, and is expected to announce its first patients by early 2018.
The Dow Jones Industrial Average gained 7.3% in 2016, while the S&P 500 added 1.7%.